ZoeNCure Therapeutics Secures License for Novel Antibody Platform from Styx Biotechnologies to Advance Next-Generation ADCs for Liver Cancer
Business Wire India ZoeNCure Therapeutics Pvt. Ltd., an oncology biotechnology company based in New Delhi, today announced a strategic licensing…